MHRA September Board Meeting Documents MHRA September Board Meeting Documents The agenda and board papers from the MHRA board meeting on 20... MHRA September Board Meeting Documents
MHRA Publishes Marketing Authorisations Granted between 1-14 October 2022 MHRA’s list of marketing authorisations granted between 1-14 October 2022 MHRA granted five OTC licences between 1-14 October 2022. Details... MHRA Publishes Marketing Authorisations Granted between 1-14 October 2022
MHRA Public Assessment Report – Reclassification of Neutrogena T/Gel Therapeutic Shampoo MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA has published the Public... MHRA Public Assessment Report – Reclassification of Neutrogena T/Gel Therapeutic Shampoo
CMDh October 2022 Meeting – Report CMDh October 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh October 2022 Meeting – Report
European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published The European Commission has published the Staff... European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published
EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making The European Medicines Agency (EMA) has... EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making
AESGP Hearing at HMPC Meeting Report – May 2022 AESGP Hearing at HMPC Meeting Report – May 2022 EMA has published the report of the AESGP hearing at the... AESGP Hearing at HMPC Meeting Report – May 2022
HMA 109th Meeting Highlights – September 2022 HMA 109th Meeting Highlights – September 2022 The Heads of Medicines Agencies (HMA) have published the highlights... HMA 109th Meeting Highlights – September 2022
Titanium Dioxide – Global Safety Review Updates Titanium Dioxide – Global Safety Review Updates AESGP has provided a summary of new developments related to titanium dioxide globablly,... Titanium Dioxide – Global Safety Review Updates
HPRA – Guidance Update HPRA – Guidance Update The Health Products Regulatory Authority (HPRA) has updated its Guide to Batch-Specific Requests... HPRA – Guidance Update
Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs The European Medicines Agency (EMA) and the... Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs
PAGB OTC Medicines Pack Design Workshop PAGB OTC Medicines Pack Design Workshop The PAGB ‘OTC Medicines Pack Design Workshop’ will take place online on Wednesday 2... PAGB OTC Medicines Pack Design Workshop
